Succinylated gelatin
- Generic Name
- Succinylated gelatin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 68915-24-2
- Unique Ingredient Identifier
- -
- Indication
补充血浆容量，预防和治疗各种原因引起的血容量不足和休克，特别是创伤性休克和失血性休克。也可用于体外循环或预防麻醉时出现的低血压。
- Associated Conditions
- -
- Associated Therapies
- Plasma Volume Replacement
Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy
- First Posted Date
- 2020-11-19
- Last Posted Date
- 2020-11-19
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 216
- Registration Number
- NCT04637308
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
The Effect of Succinylated Gelatin on the Blood Viscosity and Oxygen Delivery
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2015-12-16
- Last Posted Date
- 2015-12-17
- Target Recruit Count
- 12
- Registration Number
- NCT02631356
- Locations
- 🇨🇳
The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
Effect of Gelofusine on GLP1-receptor Imaging
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-09-04
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT02541734
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath